Redfund Capital Client Biolog Inc. and Cannabis Strategic Ventures Inc. Announce Joint Development of Water-Soluble Cannabis Technology
Redfund Capital Corporation (CSE:LOAN) is pleased to announce that portfolio client Biolog Inc. has formed a partnership with Cannabis Strategic Ventures, Inc. (OTC:NUGS), to develop water-soluble cannabis technologies to be used as ingredients for cannabis and phytocannabinoid rich-infused foods, beverages and consumer products. Under the agreement, Biolog will develop the new technologies with Cannabis Strategic Ventures and will jointly deploy marketing efforts to get the products to the marketplace.
Cannabinoids (CBD, etc.) are hydrophobic substances which are not typically soluble in water. To date, cannabis formulators have utilized various techniques to make CBD oils water compatible, but encounter many drawbacks in the existing processes. The joint development effort between Biolog Inc. and Cannabis Strategic Ventures will seek to push past these current limitations to develop a new set of functional cannabinoid ingredients that can be easily added to foods, beverages, cosmetics and other consumer products that significantly improve bioavailability and overall benefits to the human body.
Simon Yu, CEO, Cannabis Strategic Ventures comments, “We believe water-soluble cannabis technologies open new avenues for the development of cannabinoid-based products.” He added, “Over the past year we have reviewed several supposed water-soluble cannabinoids technologies but have passed on adoption due to technological limitations. The new product class that is in development with Biolog holds great potential and we are enthusiastically backing this developmental effort.”
“Working alongside Cannabis Strategic Ventures and assisting them to realize their mandate building their products brands using Biolog technology shows collaboration of incubators in the space. Branded products are the niche we believe will lead the industry just as patented medical products lead pharma for many decades. Biolog’s licensing agreements with Lexaria makes them a leader of the medical cannabis pack. This client in our portfolio looks to be our next go-public prodigy,” stated Meris Kott, CEO, Redfund Capital Corp.
About Redfund Capital
Redfund intends to provide debt and equity funding in the mid-to-late stages of a target company’s development, or in technologies that are developed and validated by revenues. The present focus of the merchant bank is on medical cannabis, hemp and CBD-related, healthcare-related target companies.
About Cannabis Strategic Ventures
Cannabis Strategic Ventures is a Los Angeles based firm that incubates, develops and partners with category leaders within the cannabis sector. The Firm’s NUGS brand experience provides mentorship and a range of essential services to emerging and existing Cannabis consumer brands.
About Biolog, Inc.
Privately held Biolog, Inc., located in the San Francisco Bay area, has been organized to capitalize on the fast growing market for cannabidiol (CBD) edibles and beverages. Biolog products solve many of the industry’s most pressing issues concerning cannabis edibles and beverages by offering precise dosing, micro-dosing, fast onset times, high bioavailability, taste masking and ease of use.
For further information on Redfund Capital please visit www.redfundcapital.com
For more information on Redfund Capital contact Meris Kott CEO 604.484.8989 or firstname.lastname@example.org
For further information on Cannabis Strategic Ventures, Inc. please contact Arlene Guzman Phone:+1-310-359-6860 Email: email@example.com
Further information about the Company is available on www.SEDAR.com under the Company’s profile.
Neither the Canadian Securities Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release. Certain statements contained in this release may constitute “forward–looking statements” or “forward-looking information” (collectively “forward-looking information”) as those terms are used in the Private Securities Litigation Reform Act of 1995 and similar Canadian laws. These statements relate to future events or future performance. The use of any of the words “could”, “intend”, “expect”, “believe”, “will”, “projected”, “estimated”, “anticipates” and similar expressions and statements relating to matters that are not historical facts are intended to identify forward-looking information and are based on the Company’s current belief or assumptions as to the outcome and timing of such future events. Actual future results may differ materially. In particular, this release contains forward-looking information relating to the business of the Company, the Property, financing and certain corporate changes. The forward-looking information contained in this release is made as of the date hereof and the Company is not obligated to update or revise any forward-looking information, whether as a result of new information, future events or otherwise, except as required by applicable securities laws. Because of the risks, uncertainties and assumptions contained herein, investors should not place undue reliance on forward-looking information. The foregoing statements expressly qualify any forward-looking information contained herein.
Both locations expand access to the state’s widest-ranging inventory of medical cannabis products for Central Florida patients
Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) (“Trulieve” or “the Company”), a leading and top-performing cannabis company based in the United States announced today the opening of two brand-new Central Florida dispensaries. The new Clearwater and Tampa locations mark the Company’s 81 st and 82 nd nationwide, respectively, widening patient access to Florida’s largest and broadest assortment of high-quality medical cannabis products.
Philip Young, CEO and Director of Lobe, stated, “We are honored to welcome Bart to our Advisory Board. His first-hand experience on and off the field are tremendously valuable as we continue our research involving mild traumatic brain injuries and PTSD. These issues are prevalent in contact sports and we believe that athletes will play a prominent role in the continued acceptance of psychedelic medicines as legitimate treatment. We look forward to working with Bart as we seek to forge long-term strategic relationships.”
HempFusion Wellness Submits Novel Foods Dossier to the United Kingdom’s Regulatory Food Safety Agency
HempFusion Wellness Inc. (TSX:CBD.U) (OTCQX:CBDHF) (FWB:8OO) (“HempFusion” or the “Company”), a leading health and wellness CBD company utilizing the power of whole-food hemp nutrition, is pleased to announce that it has submitted its dossier to the United Kingdom’s Regulatory Food Safety Agency (the “FSA”).
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210303005322/en/